CSIMarket Company Name, Ticker, Customers, else..
 
Addex Therapeutics Ltd  (NASDAQ: ADXN)
 

Addex Therapeutics Ltd's Suppliers Performance

ADXN's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
ADXN Costs vs Sales of Suppliers Growth

• More on ADXN Suppliers






Addex Therapeutics Ltd's Comment on Supply Chain


Indivior is a supplier supporting the funded research program through direct payments to third-party suppliers and additional research funding. Between August 2022 and July 2023, Indivior provided CHF 4.5 million in funding and agreed to multiple extensions of the research term. Indivior selected a compound for future development in substance use disorders and will undertake all future development of that compound. Addex retains exclusive rights to develop its own independent GABAB PAM program, including for chronic cough, and has exercised its right to select a compound for this purpose. The agreement includes milestone payments and tiered royalties based on net sales.

Addex Therapeutics Ltd's Comment on Supply Chain


Indivior is a supplier supporting the funded research program through direct payments to third-party suppliers and additional research funding. Between August 2022 and July 2023, Indivior provided CHF 4.5 million in funding and agreed to multiple extensions of the research term. Indivior selected a compound for future development in substance use disorders and will undertake all future development of that compound. Addex retains exclusive rights to develop its own independent GABAB PAM program, including for chronic cough, and has exercised its right to select a compound for this purpose. The agreement includes milestone payments and tiered royalties based on net sales.







ADXN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Addex Therapeutics Ltd 0.00 0.03 -6.73 17
SUBTOTAL 0.00 0.00 0.00 -


Sources: Addex Therapeutics Ltd's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Addex Therapeutics Ltd’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.